World's Best Scientists 2026 revealed!
Roger L. Nation

Roger L. Nation

D-Index & Metrics

Microbiology

D-Index
86
Citations
28552
World Ranking
837
National Ranking
20

Medicine

D-Index
95
Citations
33317
World Ranking
10070
National Ranking
303

Roger L. Nation publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roger L. Nation sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 300 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Roger L. Nation D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roger L. Nation sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 86 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Roger L. Nation is affiliated with Monash University in Australia and has a robust publication record in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields including Molecular Medicine, Pharmacology, Epidemiology, Pulmonary and Respiratory Medicine, and Public Health, Environmental and Occupational Health.

The primary focus areas of their work are antibiotic resistance in bacteria and antibiotics pharmacokinetics and efficacy. Additional research topics include pneumonia and respiratory infections, cystic fibrosis research advances, Vibrio bacteria studies, malaria research and control, and bacterial identification and susceptibility testing.

Recent papers authored or co-authored by Roger L. Nation include:

  • A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens, 2022, Nature Communications
  • Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward, 2021, Frontiers in Pharmacology
  • Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii, 2020, Clinical Microbiology and Infection
  • Research priorities towards precision antibiotic therapy to improve patient care, 2022, The Lancet Microbe
  • Agents of Last Resort, 2020, Infectious Disease Clinics of North America

Frequent collaborators with Roger L. Nation include:

  • Cornelia B. Landersdorfer
  • Jian Li
  • Jürgen B. Bulitta
  • Brian T. Tsuji
  • Alan Forrest

The scientist's work has been published extensively in key academic venues, including:

  • UNC Libraries
  • Antimicrobial Agents and Chemotherapy
  • Clinical Microbiology and Infection
  • International Journal of Antimicrobial Agents
  • Clinical Pharmacology & Therapeutics

Best Publications

  • Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

    Jian Li;Roger Leigh Nation;John D Turnidge;Robert W Milne

  • Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review

    Alexandre Prehn Zavascki;Alexandre Prehn Zavascki;Luciano Zubaran Goldani;Jian Li;Roger L. Nation

  • Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

    Jennifer H Moffatt;Marina Harper;Marina Harper;Paul F Harrison;John Df Hale

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

    Samira Garonzik;Jian Li;Jian Li;Visanu Thamlikitkul;David Paterson

  • Structure—Activity Relationships of Polymyxin Antibiotics

    Tony Velkov;Philip Thompson;Roger Leigh Nation;Jian Li

  • Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

    Jian Li;Roger Leigh Nation;Robert L Milne;John D Turnidge

  • Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii

    Jian Li;Craig Robert Rayner;Roger Leigh Nation;Roxanne J Owen

  • Colistin in the 21st century.

    Roger Leigh Nation;Jian Li

  • Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.

    Tony Velkov;Kade Douglas Roberts;Roger Leigh Nation;Philip Thompson

  • Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

    Ana M Sandri;Cornelia Barbara Landersdorfer;Cornelia Barbara Landersdorfer;Jovan Jacob;Marcio M Boniatti

  • Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa

    Phillip John Bergen;Jian Li;Craig Robert Rayner;Roger Leigh Nation

  • Framework for optimisation of the clinical use of colistin and polymyxin B : the Prato polymyxin consensus

    Roger Leigh Nation;Jian Li;Otto Cars;William Couet

  • Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?

    Roger Leigh Nation;Tony Velkov;Jian Li

  • Management of meningitis due to antibiotic-resistant Acinetobacter species

    Boek Lam Kim;Anton Peleg;Thomas P Lodise;Jeffrey Lipman

  • In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

    Jian Li;John D Turnidge;Robert Milne;Roger Leigh Nation

  • Dosing guidance for intravenous colistin in critically-ill patients.

    Roger L. Nation;Samira M. Garonzik;Visanu Thamlikitkul;Evangelos J. Giamarellos-Bourboulis

  • Elucidation of the Pharmacokinetic/Pharmacodynamic Determinant of Colistin Activity against Pseudomonas aeruginosa in Murine Thigh and Lung Infection Models

    Rajesh Dudhani;John D Turnidge;John D Turnidge;Kingsley Coulthard;Kingsley Coulthard;Robert Milne

  • Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

    Alexandre P. Zavascki;Luciano Z. Goldani;Guoying Cao;Silvana V. Superti

  • New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection

    Soon-Ee Cheah;Jiping Wang;Van Thi Thu Nguyen;John D. Turnidge

  • Pharmacokinetics in the aged: A review

    Edward J. Triggs;Roger L. Nation

Frequent Co-Authors

Jürgen B. Bulitta
Jürgen B. Bulitta St. Jude Children's Research Hospital
Tony Velkov
Tony Velkov University of Melbourne
Alan Forrest
Alan Forrest University at Buffalo, State University of New York
Brian T. Tsuji
Brian T. Tsuji University at Buffalo, State University of New York
John D. Turnidge
John D. Turnidge University of Adelaide
David L. Paterson
David L. Paterson University of Queensland
Andrew A. Somogyi
Andrew A. Somogyi University of Adelaide
John D. Boyce
John D. Boyce Monash University
Alexandre P. Zavascki
Alexandre P. Zavascki Federal University of Rio Grande do Sul
Ben Adler
Ben Adler Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students pursuing Microbiology in the USA often explore complementary career paths in healthcare and information management. One such option is obtaining a certified professional coder certification, which equips individuals to accurately code and classify healthcare diagnoses and procedures. This certification opens doors to roles that demand precision and knowledge of medical terminology.

Another promising pathway is becoming a Health Information Manager. Understanding the role is crucial, and the detailed health information management job description and salary resource offers insights into the responsibilities and earning potential in this growing field. This career blends healthcare expertise with administrative skills to oversee patient data effectively.

For those interested in formal education, discovering the best cahiim accredited him programs online can ensure quality learning with flexible, remote options. These programs are recognized for meeting rigorous standards and preparing graduates for certification examinations.

Additionally, accelerated options like the medical billing and coding certificate online accelerated programs allow students to quickly enter the workforce, maintaining momentum after their microbiology studies. These pathways collectively provide micro-biology students with diverse, in-demand career alternatives aligned with healthcare administration and data management.

Best Scientists Citing Roger L. Nation

Trending Scientists

Recently Published Articles